Literature DB >> 11136185

Of mice and men and elephants: metabolic rate sets glomerular filtration rate.

M A Singer1.   

Abstract

Allometric scaling deals with the functional consequences of changes in size or scale among geometrically dissimilar animals (ie, animals differing in proportions). For adult mammals ranging in size and proportion from mouse to elephant, the data describe an interdependent set of functions consisting of metabolism (measured as metabolic rate), glomerular filtration rate (GFR), effective renal plasma flow, excretion of nitrogenous waste products, cardiac output, and pulmonary function-related variables. Within this set of functions, evidence indicates that metabolic rate is the primary process. One important design feature is given by the ratio of GFR to metabolic rate. Because this ratio is independent of size, it can be generalized to all mammals in this series. The numeric value of this ratio gives the optimal GFR for each unit of metabolic rate. A simple hypothesis is proposed: metabolic rate, the primary process, sets GFR. This relationship is unidirectional. A decrease in GFR, for example, caused by nephron loss, should not lead to a change in metabolic rate. This hypothesis was tested in four natural experiments: human growth and development, thyroid dysfunction, chronic renal failure, and hibernation. The results are consistent with this hypothesis.

Entities:  

Mesh:

Year:  2001        PMID: 11136185     DOI: 10.1016/s0272-6386(01)80073-1

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  40 in total

1.  Allometric scaling of xenobiotic clearance: uncertainty versus universality.

Authors:  T M Hu; W L Hayton
Journal:  AAPS PharmSci       Date:  2001

2.  A case of autoimmune thyroiditis and membranoproliferative glomerulonephritis.

Authors:  Sevgi Gurkan; Steven Dikman; M Jeffrey Saland
Journal:  Pediatr Nephrol       Date:  2007-11-16       Impact factor: 3.714

Review 3.  Misapplications of commonly used kidney equations: renal physiology in practice.

Authors:  Mai T Nguyen; Sharon E Maynard; Paul L Kimmel
Journal:  Clin J Am Soc Nephrol       Date:  2009-03-04       Impact factor: 8.237

Review 4.  Renal adaptation during hibernation.

Authors:  Alkesh Jani; Sandra L Martin; Swati Jain; Daniel Keys; Charles L Edelstein
Journal:  Am J Physiol Renal Physiol       Date:  2013-09-18

5.  GFR normalized to total body water allows comparisons across genders and body sizes.

Authors:  Bjørn O Eriksen; Toralf Melsom; Ulla D Mathisen; Trond G Jenssen; Marit D Solbu; Ingrid Toft
Journal:  J Am Soc Nephrol       Date:  2011-07-22       Impact factor: 10.121

Review 6.  An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases.

Authors:  Gaosi Xu; Wenjun Yan; Jingzhen Li
Journal:  Clin Exp Nephrol       Date:  2014-04-22       Impact factor: 2.801

7.  An easily overlooked cause of acute kidney injury: Answers.

Authors:  Sare Gülfem Özlü; Zehra Aydin; Aylin Kilinç Uğurlu; Mehmet Boyraz; Umut Selda Bayrakçı
Journal:  Pediatr Nephrol       Date:  2021-01-07       Impact factor: 3.714

Review 8.  The proximal tubule is the primary target of injury and progression of kidney disease: role of the glomerulotubular junction.

Authors:  Robert L Chevalier
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

Review 9.  Thyroid functional disease: an under-recognized cardiovascular risk factor in kidney disease patients.

Authors:  Connie M Rhee; Gregory A Brent; Csaba P Kovesdy; Offie P Soldin; Danh Nguyen; Matthew J Budoff; Steven M Brunelli; Kamyar Kalantar-Zadeh
Journal:  Nephrol Dial Transplant       Date:  2014-02-25       Impact factor: 5.992

10.  Kidney growth in 717 healthy children aged 0-18 months: a longitudinal cohort study.

Authors:  Ida M Schmidt; Katharina M Main; Ida N Damgaard; Claudia Mau; Anna-Maarit Haavisto; Marla Chellakooty; Kirsten A Boisen; Jørgen H Petersen; Thomas Scheike; Klaus Olgaard
Journal:  Pediatr Nephrol       Date:  2004-06-17       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.